Bard buys hernia repair system
This article was originally published in Clinica
CR Bard is to add a new surgical fixation system to its line of hernia repair products, after the company acquired "substantially all the assets" of Onux Medical, a Hampton, New Hampshire-based developer of wound closure technologies for minimally invasive procedures.
You may also be interested in...
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.
The two companies announced more details about their COVID-19 vaccine development plan, including a $185m upfront payment and $113m equity investment from Pfizer.